Prodeon Medical Announces Enrollment Completion for Expander-2 Pivotal Trial
13. Januar 2025 08:00 ET
|
Prodeon Medical
Prodeon Medical completes patient enrollment for the Expander-2 Trial, a study evaluating the Urocross Expander System for LUTS due to BPH.